Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'seroconverters' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 39 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Babiker, A; Darbyshire, N; Pezzotti, P; Porter, K; Rezza, G; Walker, S; Beral, V; Coutinho, R; Del Amo, J; Gill, N; Lee, C; Meyer, L; Tyrer, F; Dabis, F; Thiebaut, R; Lawson-Ayayi, S; Meyer, L; Boufassa, F; Hamouda, O; Lorenzo, JI; Touloumi, G; Hatzakis, A; Karafoulidou, A; Katsarou, O; Brettle, R; del Romero, J; Prins, M; Coutinho, RA; van Benthem, B; Coutinho, RA; Kirk, O; Pedersen, C; Aguado, IH; Perez-Hoyos, S; Eskild, A; Bruun, JN; Sannes, M; Sabin, C; Johnson, AM; Phillips, AN; Darbyshire, JH; Francioli, P; Vanhems, P; Egger, M; Rickenbach, M; Cooper, D; Kaldor, J; Vizzard, J; Tusell, JM; Ruiz, I; Cayla, JA; de Olalla, PG; Day, NE; De Angelis, D
      Is the time from HIV seroconversion a determinant of the risk of AIDS after adjustment for updated CD4 cell counts?

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    2. Pezzotti, P; Pappagallo, M; Phillips, PN; Boros, S; Valdarchi, C; Sinicco, A; Zaccarelli, M; Rezza, G
      Response to highly active antiretroviral therapy according to duration of HIV infection

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    3. Weidle, PJ; Kityo, CM; Mugyenyi, P; Downing, R; Kebba, A; Pieniazek, D; Respess, R; Hertogs, K; De Vroey, V; Dehertogh, P; Bloor, S; Larder, B; Lackritz, E
      Resistance to antiretroviral therapy among patients in Uganda

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    4. Briones, C; Perez-Olmeda, M; Rodriguez, C; del Romero, J; Hertogs, K; Soriano, V
      Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    5. Sirivichayakul, S; Chantratita, W; Sutthent, R; Ruxrungtham, K; Phanuphak, P; Oelrichs, RB
      Survey of reverse transcriptase from the heterosexual epidemic of human immunodeficiency virus type 1 CRF01_AE in Thailand from 1990 to 2000

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    6. Robain, M; Boufassa, F; Hubert, JB; Persoz, A; Burgard, M; Meyer, L
      Cytomegalovirus seroconversion as a cofactor for progression to AIDS

      AIDS
    7. Gonzales, MJ; Machekano, RN; Shafer, RW
      Human immunodeficiency virus type 1 reverse-transcriptase and protease subtypes: Classification, amino acid mutation patterns, and prevalence in a northern California clinic-based population

      JOURNAL OF INFECTIOUS DISEASES
    8. Robain, M; Boufassa, F; Hubert, JB; Dussaix, E; Sadeg, K; Meyer, L
      Is cytomegalovirus infection a co-factor in HIV-1 disease progression?

      EPIDEMIOLOGY AND INFECTION
    9. Porter, K; Babiker, A; Walker, S; Darbyshire, J; Gill, N; Beral, V; Coutinho, R; Darbyshire, J; Gill, N; Lee, C; Meyer, L; Rezza, G; Porter, K; Babiker, A; Walker, S; Darbyshire, J; Tyrer, F; Dabis, F; Marimoutou, C; Meyer, L; Boufassa, F; Hamouda, O; Brunn, M; Pezzotti, P; Rezza, G; Lorenzo, JI; Touloumi, G; Hatzakis, A; Karafoulidou, A; Katsarou, O; Brettle, R; Del Amo, J; del Romero, J; Prins, M; Coutinho, RA; van Benthem, B; Coutinho, RA; Kirk, O; Pedersen, C; AGuado, IH; Perez-Hoyos, S; Eskild, A; Bruun, JN; Sannes, M; Sabin, C; Lee, C; Johnson, AM; Phillips, AN; Babiker, A; Darbyshire, JH; Gill, N; Porter, K; Egger, M; Francioli, P; Rickenbach, M; Cooper, D; Kaldor, J; Cooper, D; Kaldor, J; Vizzard, J; Tusell, JM; Ruiz, I; Cayla, JA; de Olalla, PG; Day, NE; De Angelis, D
      Effect of ignoring the time of HIV seroconversion in estimating changes insurvival over calendar time in observational studies: results from CASCADE

      AIDS
    10. del Amo, J; Perez-Hoyos, S; Aguado, IH; Muga, R; Egea, JM; Clotet, B; Tor, J; Ruiz, I; Tussell, J; Lorenzo, JI; del Romero, J; Barrasa, A; Rodriguez, C; Castilla, J; Garcia, S; Diez, M; Soriano, V; del Amo, J; Avino, J; Aracil, JG; Garcia, M; Brugal, T; Cayla, J; de Olaya, PG
      AIDS incubation period in Spain before highly active antiretreviral therapy

      MEDICINA CLINICA
    11. Mocroft, A; Madge, S; Johnson, AM; Lazzarin, A; Clumeck, N; Goebel, FD; Viard, JP; Gatell, J; Blaxhult, A; Lundgren, JD
      A comparison of exposure groups in the EuroSIDA study: Starting highly active antiretroviral therapy (HAART), response to HAART, and survival

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    12. Carrieri, MP; Tamalet, C; Vlahov, D; Yahi, N; Chesney, M; Moatti, JP
      Relationship between HIV-1 viral load and continued drug use in untreated infected injection drug users

      ADDICTION BIOLOGY
    13. Baillargeon, J; Borucki, M; Black, SA; Dunn, K
      Determinants of survival in HIV-positive patients

      INTERNATIONAL JOURNAL OF STD & AIDS
    14. Prins, M; Brettle, RP; Robertson, JR; Aguado, IH; Broers, B; Carre, N; Goldberg, DJ; Zangerle, R; Coutinho, RA; van den Hoek, A
      Geographical variation in disease progression in HIV-1 seroconverted injecting drug users in Europe?

      INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
    15. Porter, K; Johnson, AM; Phillips, AN; Darbyshire, JH
      The practical significance of potential biases in estimates of the AIDS incubation period distribution in the UK Register of HIV Seroconverters

      AIDS
    16. Babiker, A; Darbyshire, JH; Gill, ON; Johnson, AM; Phillips, AN; Porter, K; Beral, V; Brettle, R; Carne, C; Gilson, RJC; Goldberg, D; Hawkins, DA; Jeffries, D; Johnson, MA; McMichael, AJ; Mortimer, PP; Pozniak, A; Weber, J; Wellsteed, S
      How soon after HIV seroconversion is antiretroviral therapy initiated?

      AIDS
    17. Serraino, D; Carrieri, P; Pradier, C; Bidoli, E; Dorrucci, M; Ghetti, E; Schiesari, A; Zucconi, R; Pezzotti, P; Dellamonica, P; Franceschi, S; Rezza, G
      Risk of invasive cervical cancer among women with, or at risk for, HIV infection

      INTERNATIONAL JOURNAL OF CANCER
    18. VANHEMS P; LAMBERT J; COOPER DA; PERRIN L; CARR A; HIRSCHEL B; VIZZARD J; KINLOCHDELOES SK; ALLARD R
      SEVERITY AND PROGNOSIS OF ACUTE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ILLNESS - A DOSE-RESPONSE RELATIONSHIP

      Clinical infectious diseases
    19. TAYLOR JMG; LAW N
      DOES THE COVARIANCE STRUCTURE MATTER IN LONGITUDINAL MODELING FOR THEPREDICTION OF FUTURE CD4 COUNTS

      Statistics in medicine
    20. BERAL V; BABIKER A; BRETTLE R; CARNE C; DARBYSHIRE JH; EVANS BG; GILL ON; GILSON RJC; GOLDBERG D; HAWKINS DA; JEFFRIES D; JOHNSON AM; JOHNSON MA; MCMICHAEL AJ; MORTIMER PP; PHILLIPS AN; PORTER K; POZNIAK A; WEBER J; WELLSTEED S
      THE AIDS INCUBATION PERIOD IN THE UK ESTIMATED FROM A NATIONAL REGISTER OF HIV SEROCONVERTERS

      AIDS
    21. MASS J; HUSMAN AMD; BROUWER M; KROL A; COUTINHO R; KEET I; VANLEEUWEN R; SCHUITEMAKER H
      PRESENCE OF THE VARIANT MANNOSE-BINDING LECTIN ALLELES ASSOCIATED WITH SLOWER PROGRESSION TO AIDS

      AIDS
    22. CARDOSO MD; STURM D; KOERNER K; DENGLER T; KEROWGAN M; KUBANEK B
      ANTI-HCV ENVELOPE PREVALENCE IN BLOOD-DONORS FROM BADEN-WURTTEMBERG

      Annals of hematology
    23. BRANCATO G; PEZZOTTI P; RAPITI E; PERUCCI CA; ABENI D; BABBALACCHIO A; REZZA G; CATERINI A; FANTONI M; MONTELLA F; RAPONI GN; SOSCIA F; TERSIGNI I; TURBESSI G
      MULTIPLE IMPUTATION METHOD FOR ESTIMATING INCIDENCE OF HIV-INFECTION

      International journal of epidemiology
    24. BIRD AG; BRETTLE R; GORE SM; ROSS AJ; ALLARDICE G; GOLDBERG D; KAMINSKI E; HERRIOT R; SMITH C; DOUGLAS G; FRANCE AJ; GIBBS I; SMITH R; GREENWOOD E; RAAB GM; ROBERTSON R; SCOTT G; WHITELAW JA; YAP PL; FARRELL A; GALLOWAY E; KENNEDY D; PITHIE A
      CD4 SURVEILLANCE IN SCOTLAND - PERSPECTIVES ON SEVERE HIV-RELATED IMMUNODEFICIENCY

      AIDS
    25. ESKILD A; MAGNUS P; BREKKE T; BRUUN JN; HEGER B; FROLAND SS; MOI H; SAMDAL HH; LOVIK M; BAKKETEIG LS
      THE IMPACT OF EXPOSURE GROUP ON THE PROGRESSION RATE TO ACQUIRED-IMMUNODEFICIENCY-SYNDROME - A COMPARISON BETWEEN INTRAVENOUS-DRUG-USERS, HOMOSEXUAL MEN AND HETEROSEXUALLY INFECTED SUBJECTS

      Scandinavian journal of infectious diseases
    26. ALLIEGRO MB; DORRUCCI M; PHILLIPS AN; PEZZOTTI P; BOROS S; ZACCARELLI M; PRISTERA R; REZZA G; LEPRI AC; SINICCO A; TARANTINI G; ANGARANO G; BUCCOLIERO G; LAZZARIN A; AIUTI F; SALASSA B; CASTELLI F; VIALE P; MAZZARELLO G; BARBANERA M; COLANGELI V; ORTONA L; URSITTI MA; TIRELLI U
      INCIDENCE AND CONSEQUENCES OF PREGNANCY IN WOMEN WITH KNOWN DURATION OF HIV-INFECTION

      Archives of internal medicine
    27. STRATHDEE SA; VEUGELERS PJ; PAGESHAFER KA; MCNULTY A; MOSS AR; SCHECHTER MT; VANGRIENSVEN GP; COUTINHO RA
      LACK OF CONSISTENCY BETWEEN 5 DEFINITIONS OF NONPROGRESSION IN COHORTS OF HIV-INFECTED SEROCONVERTERS

      AIDS
    28. MERONI L; TRABATTONI D; BALOTTA C; RIVA C; GORI A; MORONI M; VILLA ML; CLERICI M; GALLI M
      EVIDENCE FOR TYPE-2 CYTOKINE PRODUCTION AND LYMPHOCYTE-ACTIVATION IN THE EARLY PHASES OF HIV-1 INFECTION

      AIDS
    29. CARRE N; MEYER L; BOUFASSA F; DEVEAU C; PERSOZ A; ROUZIOUX C; VILDE JL; BARY M; BURGARD M; DELLAMONICA P; DURANT J; GALLAIS H; MARS ME; GALLAIS J; DORMONT J; DELFRAISSY JF; LEVY A; BOUE F; BECLERE A; LEFRERE JJ; LERABLE J; JOUBERT L; CASSUTO JP; REBOULOT B; QUARANTA M; DUPONT B; BEUZELIN C; FOURNIER S; VITTECOQ D; BOLLIOT C; PECHALAT MT; HERSON S; COUTELLIER A; GASTAUT JA; DHIVER C; DROGOUL MP; SERENI D; GOMEZ V; BACHMEYER C; LEPORT C; COLASSANTE U; KATLAMA C; BRUCKER G; SOBEL A; DUVAL J; MAJERHOLC C; DEFORGES L; KAZATCHKINE M; VELLAY A; BUISSON M; LEBRAS P; GOUJARD C; QUERTAINMONT Y; ANDRIEU JM; EVEN P; GUILLEVIN L; JAROUSSE J; TROGOFF B
      HIGH-RISK OF HIV DISEASE PROGRESSION AFTER INFECTION THROUGH A SEXUALPARTNER WITH AIDS

      AIDS
    30. HERSHOW RC; GALAI N; FUKUDA K; GRABER J; VLAHOV D; REZZA G; KLEIN RS; JARLAIS DCD; VITEK C; KHABBAZ R; FREELS S; ZUCKERMAN R; PEZZOTTI P; KAPLAN JE
      AN INTERNATIONAL COLLABORATIVE STUDY OF THE EFFECTS OF COINFECTION WITH HUMAN T-LYMPHOTROPIC VIRUS TYPE-II ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DISEASE PROGRESSION IN INJECTION-DRUG USERS

      The Journal of infectious diseases
    31. MAGDER LS; ZEGER SL
      A SMOOTH NONPARAMETRIC ESTIMATE OF A MIXING DISTRIBUTION USING MIXTURES OF GAUSSIANS

      Journal of the American Statistical Association
    32. DORRUCCI M; REZZA G; VLAHOV D; PEZZOTTI P; SINICCO A; NICOLOSI A; LAZZARIN A; GALAI N; GAFA S; PRISTERA R; ANGARANO G; SERPELLONI G; CASTELLI F; VIALE P; SALASSA B; RICCHI E; BARBANERA M; ORTONA L; TIRELLI U; AIUTI F; CANESSA A; ZERBONI R; ZACCARELLI M; CIAFFI L; ALLIEGRO B; LEPRI AC
      CLINICAL CHARACTERISTICS AND PROGNOSTIC VALUE OF ACUTE RETROVIRAL SYNDROME AMONG INJECTING DRUG-USERS

      AIDS
    33. CHAKRABARTI L; BAPTISTE V; KHATISSIAN E; CUMONT MC; AUBERTIN AM; MONTAGNIER L; HURTREL B
      LIMITED VIRAL SPREAD AND RAPID IMMUNE-RESPONSE IN LYMPH-NODES OF MACAQUES INOCULATED WITH ATTENUATED SIMIAN IMMUNODEFICIENCY VIRUS

      Virology
    34. LINDBACK S; BROSTROM C; KARLSSON A; GAINES H
      DOES SYMPTOMATIC PRIMARY HIV-1 INFECTION ACCELERATE PROGRESSION TO CDC STAGE-IV DISEASE, CD4 COUNT BELOW 200 X 10(6) 1, AIDS, AND DEATH FROM AIDS/

      BMJ. British medical journal
    35. PHILLIPS AN; SABIN CA; ELFORD J; BOFILL M; JANOSSY G; LEE CA
      USE OF CD4 LYMPHOCYTE COUNT TO PREDICT LONG-TERM SURVIVAL FREE OF AIDS AFTER HIV-INFECTION

      BMJ. British medical journal
    36. ESKILD A; MAGNUS P; SOHLBERG C; JENSEN F; KITTELSEN P
      A COMPARISON OF THE PROGRESSION RATE TO ACQUIRED-IMMUNODEFICIENCY-SYNDROME BETWEEN INTRAVENOUS-DRUG-USERS AND HOMOSEXUAL MEN

      Scandinavian journal of social medicine
    37. PHILLIPS AN; PEZZOTTI P; LEPRI AC; REZZA G; DORRUCCI M; ALLIEGRO B; SINICCO A; MURATORI S; TARANTINI G; ANGARANO G; LAZZARIN A; AIUTI E; ZACCARELLI M; SALASSA B; CASTELLI F; VIALE P; CANESSA A; BARBANERA M; RICCHI E; ORTONA L; PRISTERA R; GAFA S; TIRELLI U
      CD4 LYMPHOCYTE COUNT AS A DETERMINANT OF THE TIME FROM HIV SEROCONVERSION TO AIDS AND DEATH FROM AIDS - EVIDENCE FROM THE ITALIAN SEROCONVERSION STUDY

      AIDS
    38. FLEGG PJ
      THE NATURAL-HISTORY OF HIV-INFECTION - A STUDY IN EDINBURGH DRUG-USERS

      The Journal of infection
    39. PALENICEK J; NELSON KE; VLAHOV D; GALAI N; COHN S; SAAH AJ
      COMPARISON OF CLINICAL SYMPTOMS OF HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE BETWEEN INTRAVENOUS-DRUG-USERS AND HOMOSEXUAL MEN

      Archives of internal medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/02/20 alle ore 14:07:43